We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation

This study has suspended participant recruitment.
(Study never initiated.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01209559
First Posted: September 27, 2010
Last Update Posted: January 31, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Orlando Hung, Nova Scotia Health Authority
September 23, 2010
September 27, 2010
January 31, 2017
January 2011
January 2011   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01209559 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation
Not Provided
The objective of this study is to determine if the glottic view obtained with the air-Q Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA) is better than that obtained with the traditionally used intubating laryngeal mask airway (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare effectiveness of ventilation.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA.
Airway Management
Not Provided
  • air-Q Intubating Laryngeal Airway
  • LMA FastrachTM or ILMA
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
60
Not Provided
January 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA

Exclusion Criteria:

  • history of acid reflux,
  • a BMI ≥ 40kg.m-2,
  • require endotracheal intubation,
  • have predictors of difficult intubation,
  • not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm,
  • cannot consent to the study
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT01209559
CDHA-RS/2011-156
Not Provided
Not Provided
Not Provided
Orlando Hung, Nova Scotia Health Authority
Nova Scotia Health Authority
Not Provided
Not Provided
Nova Scotia Health Authority
January 2017